[PDF] Top 20 Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.
Has 10000 "Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study." found on our website. Below are the top 20 most common "Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.".
Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.
... T Secondary acute myeloid leukemia (sAML) has been associated with inferior outcomes compared with de novo ...factors and outcomes in sAML after allogeneic hematopoietic ... Voir le document complet
9
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3internal tandem duplication: A position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
... 1 Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; 2 Department of Anatomy, Cell Biology, ... Voir le document complet
10
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
... with the non-T-depleted and post-transplantation cyclo- phosphamide (PTCy) approach, outcomes of HaploSCT have begun to equate to those of alloSCT from siblings which are ... Voir le document complet
13
Prediction of Hematopoietic Stem Cell Transplantation Related Mortality-Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study
... Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel- Hashomer, Ramat-Gan, Israel, 2 Internal medicine "F" Department and ... Voir le document complet
15
Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
... availability of more sensitive assays for MRD has implications in treatment decisions, response evaluations, and MRD status after therapy potentially represents a new endpoint in clinical research ... Voir le document complet
12
Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
... standard of care in that set- ting (Table 4) although ATG has also been associated with infusion reactions, delayed hematopoietic and immune recovery, and increased risks of cytomegalovirus ... Voir le document complet
12
Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation
... by the European Society for Blood and Marrow Transplanta- tion (EBMT) Acute Leukaemia (AML) Working Party, aimed to explore the role of ... Voir le document complet
4
Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood—a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation
... in the field in the last decades [8], nonrelapse mortality (NRM) has remained the main cause of failure of UCBT for AML ...In the setting of allogeneic HLA-matched ... Voir le document complet
12
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
... Methods Study design and data collection This was a retrospective multicenter analysis using the dataset of the Acute Leukemia Working Party (ALWP) of ... Voir le document complet
12
The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party
... feasibility of haplo-identical SCT performed with T replete stem cell grafts and in vivo T cell depletion based either on ATG [32] or post-transplant cyclophos- phamide [33] has been demonstrated in ... Voir le document complet
15
Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
... cell transplantation (allo-SCT) is the most effective post-remission treatment for adults with high-risk acute lymphoblastic leukemia ...(ALL). The aim of the ... Voir le document complet
12
Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT.
... Patients and Methods Data collection This is a retrospective, multicenter registry-based study performed by the Acute Leukemia Working Party (ALWP) of the ... Voir le document complet
7
Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT
... Patients and Methods Data collection This is a retrospective, multicenter registry-based study performed by the Acute Leukemia Working Party (ALWP) of the ... Voir le document complet
8
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT
... Methods Study design and data collection This was a retrospective multicenter ...provided and approved for this study by the acute leukemia working ... Voir le document complet
13
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
... model for overall mortality (OM) at day 100. The ADT consists of alternating levels of prediction (ellipses) and decision nodes ...to the cumulative prediction score, whereas ... Voir le document complet
10
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT
... INTRODUCTION The introduction of reduced intensity (RIC) allogeneic stem cell transplantation into the mainstay of clinical management of older patients with acute ... Voir le document complet
8
Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: Higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood-a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation
... effects of chronic GVHD? Previous studies in the bone marrow or peripheral blood setting have demonstrated a strong link between chronic GVHD occurrence and a lower risk ... Voir le document complet
11
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
... (MAC) and reduced-intensity conditioning (RIC) or nonmyeloablative (NMA) based on the expected duration of the pancyto- penia (irreversible, prolonged, minimal) and on the ... Voir le document complet
12
Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
... to the posttrans- plant use of imatinib was performed by a German group German multicenter study group for adult acute lympho- blastic leukemia ...prophylactic and ... Voir le document complet
11
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
... Four outcomes were evaluated in this series: (i) non-relapse mor- tality, defined as death without previous relapse; (ii) relapse inci- dence, defined on the basis of morphological evidence of ... Voir le document complet
8
Sujets connexes